Marshall Wace
VIR icon

Marshall Wace’s Vir Biotechnology VIR Stock Holding History

Marshall Wace’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,557
Closed -$173K – 3126
2024
Q4 		$173K Buy
+23,557
New +$186K ﹤0.01% 2379
2023
Q3 		– Sell
-73,641
Closed -$1.81M – 2729
2023
Q2 		$1.81M Sell
73,641
-9,920
-12% -$249K ﹤0.01% 1451
2023
Q1 		$1.94M Sell
83,561
-114,429
-58% -$2.93M ﹤0.01% 1470
2022
Q4 		$5.01M Sell
197,990
-148,286
-43% -$3.63M 0.01% 1184
2022
Q3 		$6.68M Buy
346,276
+90,200
+35% +$2.29M 0.01% 1169
2022
Q2 		$6.52M Buy
+256,076
New +$5.98M 0.01% 1158
2022
Q1 		– Sell
-352,171
Closed -$14.7M – 4063
2021
Q4 		$14.7M Buy
352,171
+293,552
+501% +$11.5M 0.03% 624
2021
Q3 		$2.55M Buy
+58,619
New +$2.54M 0.01% 1376
2021
Q2 		– Sell
-39,560
Closed -$2.03M – 3124
2021
Q1 		$2.03M Buy
+39,560
New +$2.13M 0.01% 1318

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return